Patent 7785571 was granted and assigned to NeuTec Pharma Ltd. on August, 2010 by the United States Patent and Trademark Office.
A composition comprising an antibody or an antigen binding fragment thereof specific for at least one epitope of hsp90 from an organism of the Aspergillus genus, and at least one antifungal agent selected from the group consisting of: itraconazole and voriconazole.